Clinerion’s Patient Network Explorer offers indication-agnostic access to live, real-world, de-identified, aggregate EMR data of its partner hospitals.

Extract: Multiple Myeloma in Türkiye

In this example, the Patient Network Explorer was used to develop multiple myeloma Charlson comorbidity scores and co-treatment regime models.

Identified patients in Türkiye with multiple myeloma with first diagnosis in 2018 were evaluated on:

Figure 1: Patient demographics in multiple myeloma-identified 2018-first-instance Patient Network Explorer patients  in Clinerion's hosptial network in Türkiye.

At baseline event (first diagnosis with multiple myeloma):

Figure 2: Charlson Comorbidity Index scores for multiple myeloma-identified 2018-first-instance Patient Network Explorer patients in Türkiye in Clinerion's hospital network.
 

Figure 3. Bortezomib treatment regimens in multiple myeloma-identified 2018-first-instance Patient Network Explorer patients in Türkiye in Clinerion's hospital network.

Personal Data Protection Statement

The information you provide allows us to provide you with information and updates on Clinerion’s products and services (the purpose). By submitting your details in the registration form, you give explicit consent that your personal details may be used for this and only this purpose by Clinerion and webinar partners, who may also provide you with information and updates on their products and services.

Clinerion, as the data controller and processor, will maintain the data for as long as the data is required for the purposes mentioned above, or until you withdraw consent as stated below. Personal data are not kept longer than necessary and are processed in a manner that ensures appropriate security and confidentiality, including for preventing unauthorized access to or use of personal data and the equipment used for the processing.

We will not sell or give away any personal information that you provide and only use it for the purposes stated above. You may request to view, correct, or delete your data in Clinerion’s database or withdraw consent by contacting info@clinerion.com. Please note that withdrawal of consent shall not affect the lawfulness of Clinerion’s use of your personal data for the purposes mentioned above before withdrawal of consent.

The legal address of Clinerion: Clinerion Ltd, Elisabethenanlage 11, 4051 Basel, Switzerland. e-Mail address info@clinerion.com.

Go back to the Webinars page >